Renal cell carcinoma

Results: 540



#Item
1POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

Add to Reading List

Source URL: www.seecch2010.org

Language: English - Date: 2011-05-26 11:32:25
    2Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

    Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

    Add to Reading List

    Source URL: nordiqc.org

    Language: English - Date: 2017-12-14 05:05:27
      3· RENAL CELL CARCINOMA · Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD Keywords: Biomarkers, renal cell carcin

      · RENAL CELL CARCINOMA · Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD Keywords: Biomarkers, renal cell carcin

      Add to Reading List

      Source URL: gotoper-com.s3.amazonaws.com

      - Date: 2016-09-06 09:15:40
        4www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

        www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

        Add to Reading List

        Source URL: www.ijcasereportsandimages.com

        Language: English - Date: 2016-07-21 00:58:23
        5sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

        sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

        Add to Reading List

        Source URL: observantnomad.com

        Language: English - Date: 2016-08-22 06:47:54
        6It is not breathing, call local emergency sorafenib india price services at 911. As with

        It is not breathing, call local emergency sorafenib india price services at 911. As with "sleep-driving", patients usually do not get paid until the symptoms of a doctor. Whether you buy medications online. MAO inhibitor

        Add to Reading List

        Source URL: observantnomad.com

        Language: English - Date: 2016-08-21 20:50:58
        7Repeat in 2 to 5 years: sorafenib 200 mg cipla IV: 0.2 to 0.5 mg 3 to 4 hours. Don’t stop using the drug in question. Alprazolam may be recommended as part of the type of interventions, services and hotlines. Protect y

        Repeat in 2 to 5 years: sorafenib 200 mg cipla IV: 0.2 to 0.5 mg 3 to 4 hours. Don’t stop using the drug in question. Alprazolam may be recommended as part of the type of interventions, services and hotlines. Protect y

        Add to Reading List

        Source URL: milfordk12.org

        Language: English - Date: 2016-08-19 10:20:15
        8what is sorafenib. sorafenib tyrosine kinase sorafenib sunitinib everolimus. sorafenib rad001 tipifarnib sorafenib sorafenib bayer sorafenib patient comments. sorafenib dosage. il-2 and sorafenib versus sorafenib trial p

        what is sorafenib. sorafenib tyrosine kinase sorafenib sunitinib everolimus. sorafenib rad001 tipifarnib sorafenib sorafenib bayer sorafenib patient comments. sorafenib dosage. il-2 and sorafenib versus sorafenib trial p

        Add to Reading List

        Source URL: observantnomad.com

        Language: English - Date: 2016-08-18 20:00:51
        9Birt-Hogg-Dubé syndrome: diagnosis and management

        Birt-Hogg-Dubé syndrome: diagnosis and management

        Add to Reading List

        Source URL: www.bhdsyndrome.org

        Language: English - Date: 2011-03-17 20:08:21
        10Updated immunologic and clinical results from a phase 2 study of AGS-003, an autologous dendritic cell based therapy, in patients with newly diagnosed metastatic renal cell carcinoma in combination with sunitinib. R. A.

        Updated immunologic and clinical results from a phase 2 study of AGS-003, an autologous dendritic cell based therapy, in patients with newly diagnosed metastatic renal cell carcinoma in combination with sunitinib. R. A.

        Add to Reading List

        Source URL: www.argostherapeutics.com

        Language: English - Date: 2013-12-05 12:55:52